Creative Medical Technology Holdings (CELZ) Payables (2010 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Payables for 17 consecutive years, with $684401.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 159.78% year-over-year to $684401.0 in Q2 2026; TTM through Jun 2026 was $684401.0, a 159.78% increase from a year earlier, with the FY2025 full-year figure at $270686.0, down 1.04% from the prior year.
• Payables was $684401.0 for Q2 2026 at Creative Medical Technology Holdings, up from $293455.0 in the prior quarter.
• Over five years, Payables peaked at $3.3 million in Q4 2022 and troughed at $247159.0 in Q3 2025.
• A 5-year average of $496252.4 and a median of $323516.5 in 2022 frame the typical range for Payables.
• Across the five-year window, Payables soared 322.87% in 2022 and tumbled 90.33% in 2023, its largest moves.
• Over 5 years, Payables stood at $3.3 million in 2022, then plunged by 90.33% to $317280.0 in 2023, then dropped by 13.79% to $273530.0 in 2024, then retreated by 1.04% to $270686.0 in 2025, then surged by 152.84% to $684401.0 in 2026.
• The last three Payables figures came in at $684401.0 (Q2 2026), $293455.0 (Q1 2026), and $270686.0 (Q4 2025), per Business Quant data.